Photodynamic therapy for anal cancer.
Invasive anal cancers are generally successfully treated by combined chemotherapy with radiation therapy (XRT). For those patients who locally fail this intervention many are salvaged by surgery which generally results in permanent colostomy. We examined the treatment and outcome of Photofrin based photodynamic therapy (PDT) in a cohort of patients with anal cancer who failed locally despite chemo-radiation (N=6) and two patients with positive margins of resection after excision of small T(1) squamous cell anal cancers who refused further surgery or chemo-radiation. PDT consisted of outpatient infusion of Photofrin at 1.2mg/kg followed 48 h later by outpatient illumination. Red light (630 nm) illumination was delivered by a 5 cm diffusing fiber, treating transphincterally at 300 J/cm followed by microlens illumination at 200 J/cm(2) to the perianal tumor bed with 2 cm margin. All patients completed PDT without incident and all have maintained local control of disease in the anal region for the length of follow up (18-48 months). PDT may serve as a new means to salvage local failures and perhaps could be employed as a primary treatment modality in select patients with early stage of disease.
Allison
Ron R
RR
21(st) Century Oncology, Greenville, NC, USA.
Sheng
Chao
C
Cuenca
Rosa
R
Bagnato
Vanderlei S
VS
Austerlitz
Carlos
C
Sibata
Claudio H
CH
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001005:Anus Neoplasms / Q000532:radiotherapy*; D017323:Dihematoporphyrin Ether / Q000627:therapeutic use*; D006801:Humans; D010778:Photochemotherapy
D000970:Antineoplastic Agents; D017323:Dihematoporphyrin Ether